Answer
It is an antibody–cytotoxic conjugate. The antibody targets BCMA on myeloma cells and carries a cell-killing component into them.
Sources for this answer
- Blenrep 100mg & 70 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.